Deep tech and science early stage investments

2050 Capital is an early stage tech, deep tech and science investment syndicate. We invest in transformative and defensible innovation that impacts large fundamental sectors.

2050 Capital in Figures

  • 28 investments
  • 2 Unicorns
  • 75% up-rounds
  • 2 Exits

Portfolio

AMFG

Additive Manufacturing execution system & workflow automation software

Biofourmis

Personal predictive care enabled by ML

Hadean

Distributed, spatial and scalable computing for web 3.0 and the metaverse

Neuroglee

Digital therapeutics for neurodegenerative diseases

Origin Sciences

Diagnostics of gastro-intestinal conditions using genomic sequencing

Qoala

Insuretech platform

Snyk

Open source security for developers

Vaticle

Knowledge graph database and query language

Vauban

Fund formation and governance platform

View All

News

Indonesian insurtech startup Qoala banks US$65M Series B led by Eurazeo’s Tara Reeves

E27, May 2022

Health AI Startup Biofourmis Hits $1.3 Billion Valuation With Series D Funding

Forbes, Apr 2022

Aquant raised $70 million in Series C funding

Business Wire, Oct 2021

Snyk raises $530 million on an $8.5 billion valuation

Techcrunch, Sep 2021

View All